Host Control of Tumor Growth-Reference-Cited by-同舟云学术

Host Control of Tumor Growth

Published:1977-08-05 Issue:4303 Volume:197 Page:571-573
ISSN:0036-8075
Container-title:Science
language:en
Short-container-title:Science

Author:

Ting C. C.¹,Tsai S. C.²,Rogers M. J.¹

Affiliation:

1. Laboratory of Cell Biology, National Cancer Institute, National Institutes of Health, Bethesda, Maryland 20014

2. Laboratory of Cellular Metabolism, National Heart and Lung Institute, Bethesda, Maryland 20014

Publisher

American Association for the Advancement of Science (AAAS)

Subject

Multidisciplinary

Reference14 articles.

1. BALDWIN, R, DETECTION OF CIRCULATING HEPATOMA D23 ANTIGEN AND IMMUNE COMPLEXES IN TUMOR BEARER SERUM, BRITISH JOURNAL OF CANCER 28: 16 (1973).

2. BALDWIN, R.W., BLOCKING OF LYMPHOCYTE-MEDIATED CYTOTOXICITY FOR RAT HEPATOMA-CELLS BY TUMOR-SPECIFIC ANTIGEN-ANTIBODY COMPLEXES, NATURE-NEW BIOLOGY 238: 185 (1972).

3. BONAVIDA, B, STUDIES ON INDUCTION AND EXPRESSION OF T CELL-MEDIATED-IMMUNITY .1. BLOCKING OF CELL-MEDIATED CYTOLYSIS BY MEMBRANE ANTIGENS, JOURNAL OF IMMUNOLOGY 112: 926 (1974).

4. BONNARD, G.D., IMMUNOSUPPRESSIVE ACTIVITY OF A SUBLINE OF MOUSE EL-4 LYMPHOMA - EVIDENCE FOR MINUTE VIRUS OF MICE CAUSING INHIBITION, JOURNAL OF EXPERIMENTAL MEDICINE 143: 187 (1976).

5. COOPERBAND, S.R., EFFECT OF IMMUNOREGULATORY ALPHA GLOBULIN (IRA) UPON LYMPHOCYTES IN-VITRO, JOURNAL OF IMMUNOLOGY 109: 154 (1972).

Cited by 21 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Differential modulation of host macrophage function by AK-5 tumor is dependent on the site of tumor transplantation;Immunology Letters;2002-07

2. Reversal of multiple-site tumor cell-induced immunosuppression by specific cytokines and pharmacological agents;Immunopharmacology;1995-08

3. Immunosuppression by Metastatic Tumors;Influence of the Host on Tumor Development;1989

4. Immunosuppressive Factors in Ascites Fluids From Ovarian Cancer Patients;American Journal of Reproductive Immunology;1984-12

5. Detection of a suppressive immunoregulatory factor (IRF) in the sera of sarcoma patients by enzyme-linked immunoassay (ELISA) and correlation with clinical course;Journal of Surgical Oncology;1983-08